Plain-English translation of NCT07552389 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Hypertension research guide โPhase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing HL1113 โ a combination medication designed to treat both high blood pressure and type 2 diabetes โ by comparing it against two separate single-ingredient pills that do similar jobs. Researchers want to know if the medication works better, worse, or the same when you take it as one pill versus two separate pills. The results will help doctors decide which approach is most helpful for patients managing both conditions.
Many patients struggle to manage two conditions at once, and taking fewer pills might help them stick to their treatment plan. This trial will show whether this medication is just as effective in simpler dosing forms, which could make life easier for people with both high blood pressure and diabetes.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this trial, you will be randomly assigned to take either two single pills or one combination pill for a set period of time. You'll visit the clinic multiple times so doctors can monitor your blood pressure and blood sugar levels, and check how well the medication is working and whether you experience any side effects. The study will compare how effective each approach is at controlling your conditions.
AI-generated summary from trial data ยท Jun 1, 2026 ยท Not medical advice
South Korea